Abhinav Mehta
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems 12
- Drug Solubulity and Delivery Systems 5
- Advancements in Transdermal Drug Delivery 2
- Molecular Medicine top 2%
- Hydrogels: synthesis, properties, applications 3
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 2
-
- Immunotherapy and Immune Responses 7
- Food Science top 10%
-
- RNA Interference and Gene Delivery 7
-
- Inhalation and Respiratory Drug Delivery 2
- Co-authors
- Ankur BhardwajShuchi MehtaSuresh P. VyasAmit K. GoyalNeeraj MishraKapil KhatriRishi PaliwalBhuvaneshwar Vaidya
- Journals
- Journal of Clinical Oncology (1 paper)Journal of Controlled Release (3 papers)International Journal of Pharmaceutics (1 paper)
- Partner nations
- IndiaUnited StatesFrance
In The Last Decade
Abhinav Mehta
26 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 105
- Pharmaceutical Science 625
- Molecular Medicine 195
- Biomaterials 385
- Immunology 167
- Food Science 135
Countries citing papers authored by Abhinav Mehta
This map shows the geographic impact of Abhinav Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abhinav Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abhinav Mehta more than expected).
Fields of papers citing papers by Abhinav Mehta
This network shows the impact of papers produced by Abhinav Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abhinav Mehta. The network helps show where Abhinav Mehta may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Abhinav Mehta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 38 | |
| 2 | 2015 | 27 | |
| 3 | 2014 | 155 | |
| 4 | 2013 | 4 | |
| 5 | 2013 | 5 | |
| 6 | 2013 | 26 | |
| 7 | 2012 | 22 | |
| 8 | 2011 | 22 | |
| 9 | 2010 | 45 | |
| 10 | Formulation and Evaluation of Solid Dispersions of an Anti-diabetic Drug | 2009 | 5 |
| 11 | 2009 | 60 | |
| 12 | 2009 | 68 | |
| 13 | 2009 | 44 | |
| 14 | 2009 | 12 | |
| 15 | 2009 | 28 | |
| 16 | 2008 | 86 | |
| 17 | 2008 | 96 | |
| 18 | 2008 | 35 | |
| 19 | 2008 | 231 | |
| 20 | Efficacy of low dose intradermal recombinant hepatitis B vaccine with and without immunomodulation in end stage renal disease patients on maintenance hemodialysis. | 1995 | 1 |
About Abhinav Mehta
Abhinav Mehta is a scholar working on Pharmaceutical Science, Molecular Medicine and Immunology, having authored 26 papers that have together received 1.4k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (12 papers), RNA Interference and Gene Delivery (7 papers), Immunotherapy and Immune Responses (7 papers), Drug Solubulity and Delivery Systems (5 papers), Hydrogels: synthesis, properties, applications (3 papers), Advancements in Transdermal Drug Delivery (2 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Pharmaceutical Science (625 citations), Molecular Medicine (195 citations) and Biomaterials (385 citations). Abhinav Mehta has collaborated with scholars based in India, United States and France. Frequent co-authors include Ankur Bhardwaj, Shuchi Mehta, Suresh P. Vyas, Amit K. Goyal, Neeraj Mishra, Kapil Khatri, Rishi Paliwal, Bhuvaneshwar Vaidya, Prem N. Gupta and Shivani Rai. Their work appears in journals such as Journal of Clinical Oncology, Journal of Controlled Release and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.